Clinical Trials Logo

Clinical Trial Summary

Osteoarthritis (OA) is a highly progressive and debilitating joint disease. Recently, it was demonstrated the existence of an important link between OA inflammation and progression of structural changes. Therapy with intra-articular injection of stromal vascular fraction (SVF) holds great promises and its efficacy could be further augmented with the addition of biological adjuvants. In the present project, we aim at demonstrating that human platelet lysate (HPL) increases the intrinsic beneficial properties of SVF on cartilage regeneration and joint environment. Moreover, we want to verify if SVF-conditioned medium (CM) obtained from SVF primed with HPL yields comparable or superior outcomes than whole SVF.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Assessment of the Trophic and Anti-inflammatory Effect of SVF Added With HPL
  • Osteoarthritis

NCT number NCT04225481
Study type Observational
Source Istituto Ortopedico Galeazzi
Contact Silvia Palombella, PhD
Phone 02 66214061
Email silvia.palombella@grupposandonato.it
Status Not yet recruiting
Phase
Start date January 2020
Completion date July 2022